Parkinson’s Foundation, Fulgent Genetics Partner on Genetic Testing Initiative

The Parkinson’s Foundation and Fulgent Genetics announced that they have begun collaboration on a new genetic testing initiative for Parkinson’s disease patients. Fulgent said it will apply a customized version of its Parkinson’s disease next-generation sequencing panel to target seven genes linked to Parkinson’s disease, including GBA, LRRK2, SNCA, PRKN, PARK7, and PINK1. The firm will analyze the genes and generate targeted clinical reports, which will be available to the treating physicians and future researchers.

Source: https://www.genomeweb.com/sequencing/parkinsons-foundation-fulgent-genetics-partner-genetic-testing-initiative